About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Glaxosmithkline Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
115.94
NSE Code
GLAXO
Dividend Yield %
1.64
Market Cap
556617.41
P/E
60.56
EPS
54.25
Face Value
10
BSE
NSE
04-Jul-2025
BSE
NSE
NSE F & O
04-Jul-2025
BSE
NSE
NSE F & O
Last Price
3285.70
Net Change
-12.6
% Change
-0.38%
Prev.Close
3298.30
Open
3310.00
High
3344.05
Low
3274.10
Volume
1537
Last Price
3283.70
Net Change
-18.3
% Change
-0.55%
Prev.Close
3302.00
Open
3303.00
High
3348.00
Low
3275.00
Volume
78280
Value
5092103
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
3344.05
52-Week High
3515.95
52-Week Low
1924.30
Value
258728049.7
Best Buy
0.00
Best Sell
3283.70
Best Quantity
0
Sell Quantity
294
Today's Range
3348.00
52-Week High
3515.70
52-Week Low
1921.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
294
Price
3283.70
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 1
11-Sep-18
Book Closure
15-Jul-19
22-Jul-19
Dividend
420 %
30-May-25
Company News
20-06-2025
GlaxoSmithKline Pharmaceu...
15-05-2025
GlaxoSmithKline Pharmaceu...
15-05-2025
GlaxoSmithKline Pharmaceu...
15-05-2025
GlaxoSmithKline Pharmaceu...
13-05-2025
GlaxoSmithKline Pharmaceu...
13-05-2025
GlaxoSmithKline Pharmaceu...
25-04-2025
GlaxoSmithKline Pharmaceu...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
